31 related articles for article (PubMed ID: 34850542)
1. Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1.
Hua YQ; Zhu YD; Xie GQ; Zhang K; Sheng J; Zhu ZF; Ning ZY; Chen H; Chen Z; Meng ZQ; Liu LM
Aging (Albany NY); 2019 Nov; 11(20):8860-8878. PubMed ID: 31619579
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA RAD51-AS1 promotes the tumorigenesis of ovarian cancer by elevating EIF5A2 expression.
Zhao L; Huang J; Liu W; Su X; Zhao B; Wang X; He X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):179. PubMed ID: 38584230
[TBL] [Abstract][Full Text] [Related]
3. Knocking down of lncRNA SBF2-AS1 inhibits proliferation, invasion and induces apoptosis of colorectal cancer through regulating PTEN.
Cai Y; Yan H; Wang F; Xie L
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):201-205. PubMed ID: 38279439
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA UNC5B-AS1 suppresses cell proliferation by sponging miR-24-3p in glioblastoma multiforme.
Song Y; Chen B; Jiao H; Yi L
BMC Med Genomics; 2024 Apr; 17(1):83. PubMed ID: 38594690
[TBL] [Abstract][Full Text] [Related]
5. ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer.
Kim HW; Baek M; Jung S; Jang S; Lee H; Yang SH; Kwak BS; Kim SJ
Epigenetics; 2023 Dec; 18(1):2276384. PubMed ID: 37908128
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of long non-coding RNA SBF2-AS1 promotes cell progression in esophageal squamous cell carcinoma (ESCC) by repressing miR-494 to up-regulate PFN2 expression.
Zhang Q; Pan X; You D
Biol Open; 2020 Mar; ():. PubMed ID: 32229486
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LOC646029 functions as a ceRNA to suppress ovarian cancer progression through the miR-627-3p/SPRED1 axis.
Zhao P; Wang Y; Yu X; Nan Y; Liu S; Li B; Cui Z; Liu Z
Front Med; 2023 Oct; 17(5):924-938. PubMed ID: 37434064
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA KCNMB2-AS1 acts as an oncogene in ovarian cancer.
Cao S; Liu M; Guo Z; Li Y
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1844-1846. PubMed ID: 37710992
[No Abstract] [Full Text] [Related]
9. The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action.
Pandini C; Pagani G; Tassinari M; Vitale E; Bezzecchi E; Saadeldin MK; Doldi V; Giannuzzi G; Mantovani R; Chiara M; Ciarrocchi A; Gandellini P
Cell Death Dis; 2024 Mar; 15(3):206. PubMed ID: 38467619
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA SBF2 Antisense RNA 1 Facilitates Ovarian Cancer Metastasis via Enhancing β-Catenin Stability and Triggering the Wnt/β-Catenin Signal.
Hou LL; Luan AA; Zhao P
Tohoku J Exp Med; 2022 Nov; ():. PubMed ID: 36436927
[No Abstract] [Full Text] [Related]
11. Statement of Retraction: Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.
Bioengineered; 2024 Dec; 15(1):2299622. PubMed ID: 38376894
[No Abstract] [Full Text] [Related]
12. Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo.
Qi ZY; Wang F; Yue YY; Guo XW; Guo RM; Li HL; Xu YY
J Ovarian Res; 2023 Aug; 16(1):174. PubMed ID: 37626400
[No Abstract] [Full Text] [Related]
13. Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis.
Salamini-Montemurri M; Lamas-Maceiras M; Lorenzo-Catoira L; Vizoso-Vázquez Á; Barreiro-Alonso A; Rodríguez-Belmonte E; Quindós-Varela M; Cerdán ME
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445988
[TBL] [Abstract][Full Text] [Related]
14. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of long noncoding RNA linc02544 and its association with overall survival rate and the influence on cell proliferation and migration in lung squamous cell carcinoma.
Wei W; Xu T; Zhang Y; Huang Y; Wang X
Discov Oncol; 2022 May; 13(1):41. PubMed ID: 35635595
[TBL] [Abstract][Full Text] [Related]
16. Silencing of SBF2-AS1 inhibits cell growth and invasion by sponging microRNA-338-3p in serous ovarian carcinoma.
Luan AA; Hou LL; Zhang FY
Kaohsiung J Med Sci; 2022 Apr; 38(4):302-311. PubMed ID: 34850542
[TBL] [Abstract][Full Text] [Related]
17. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
Wang A; Wang J
DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SBF2-AS1 Facilitates Nonsmall Cell Lung Cancer Progression by Targeting miR-520a-3p.
Wang Y; Zou Y; Zhang Q; Chen D; Lin L
J Healthc Eng; 2022; 2022():2223149. PubMed ID: 35444785
[TBL] [Abstract][Full Text] [Related]
19. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J
Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
